Guru Ownership Trend
Guru Analysis for Coherus Oncology, Inc. (CHRS)
Coherus Oncology, Inc. (CHRS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.88 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $626,881.64 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 140.5%. Conversely, Jefferies Group reduced exposure by 36.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Coherus Oncology, Inc. (CHRS)
Major holders include Cliff Asness ($2.04 M), Renaissance Technologies (RenTech) ($560,573), Jefferies Group ($425,880). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.79 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $626,881.64, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited CHRS. The total reported sell value was $241,991.1.
Yes, 0 managers opened new positions in CHRS, and 2 increased their existing holdings. The total reported buy value was $868,872.74.